Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00792766
What this trial is testing

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous SclerosisAngiolipoma
Children's Hospital Medical Center, Cincinnati 20
Large-scale testing (Phase 3)Ended earlyNCT04291456
What this trial is testing

Minocycline in MS: Confirmation of Benefit

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
University of Calgary 9
Not applicableStudy completedNCT02695394
What this trial is testing

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 60
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Not applicableStudy completedNCT01106365
What this trial is testing

Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 36
Not applicableStudy completedNCT04403594
What this trial is testing

Functional Intermuscular Reduction of Spasticity

Who this might be right for
Multiple Sclerosis
University of Oklahoma 16
Post-approval studies (Phase 4)Study completedNCT01591551
What this trial is testing

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Cornerstone Health Care, PA 37
Not applicableStudy completedNCT03736902
What this trial is testing

Views on Physical Activity Following a Relapse in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
City, University of London 15
Not applicableStudy completedNCT00238654
What this trial is testing

Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 257
Not applicableEnded earlyNCT04748302
What this trial is testing

Impaired Glucose Tolerance and Cognition in MS

Who this might be right for
Multiple Sclerosis
University of Virginia 7
Not applicableStudy completedNCT03399981
What this trial is testing

Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Biogen 80,327
Not applicableStudy completedNCT05393765
What this trial is testing

The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Selcuk University 76
Not applicableStudy completedNCT05188937
What this trial is testing

Validity and Reliability of the Dual-task Questionnaire

Who this might be right for
Multiple Sclerosis
Gazi University 50
Not applicableAvailableNCT06802328
What this trial is testing

Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
Large-scale testing (Phase 3)Looking for participantsNCT04302870
What this trial is testing

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
University of Edinburgh 1,150
Early research (Phase 1)Study completedNCT01585766
What this trial is testing

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing Forms
MedImmune LLC 56
Not applicableStudy completedNCT01080053
What this trial is testing

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 306
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765212
What this trial is testing

Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Eva M.M. Strijbis 75
Not applicableStudy completedNCT06854341
What this trial is testing

A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Novartis Pharmaceuticals 5,448
Not applicableNot Yet RecruitingNCT06415552
What this trial is testing

Implementation of Online Mindfulness-Based Stress Reduction Tailored for People with Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Robert Simpson 120
Next Page